Curtis Lachowiez

Expert in hematological malignancies at Oregon Health & Science University. Shared insights into the combination of Venetoclax with purine analog-based regimens.

Best podcasts with Curtis Lachowiez

Ranked by the Snipd community

Mar 28, 2025 • 23min

Approaches to optimizing induction therapy in AML: FLT3 inhibitors, menin inhibitors, CPX-351, & more!

Selina Luger, an expert in leukemias, and Curtis Lachowiez, a hematological malignancies authority, discuss groundbreaking strategies for optimizing induction therapy in acute myeloid leukemia. They delve into the exciting results of combining venetoclax with traditional chemotherapy, showcasing enhanced remission rates. Additionally, Luger shares insights from trials comparing FLT3 inhibitors, while Lachowiez highlights the potential of menin inhibitors like Ziftomenib. The conversation also touches on the effectiveness of CPX-351 and future advancement directions in AML treatment.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app